Adams, S., Pill, R., & Jones, A. (1997). Medication, chronic illness and identity: The perspective of people with asthma. Social Science and Medicine,45(2), 189–201.
CAS
Article
Google Scholar
Adams, W. E., Todorova, I. L. G., Guzzardo, M. T., & Falcón, L. M. (2015). ‘The problem here is that they want to solve everything with pills’: Medication use and identity among Mainland Puerto Ricans. Sociology of Health and Illness,37(6), 904–919. https://doi.org/10.1111/1467-9566.12240.
Article
PubMed
Google Scholar
Armstrong, K. S., & Temmingh, H. (2017). Prevalence of and factors associated with antipsychotic polypharmacy in patients with serious mental illness: Findings from a cross-sectional study in an upper-middle-income country. Brazilian Journal of Psychiatry,39(4), 293–301.
Article
Google Scholar
Bentley, K. J. (2010). Psychiatric medication and meaning-making in a residential program for adults with serious mental illness. Qualitative Social Work,9, 479–499.
Article
Google Scholar
Carter, S. R., Moles, R., White, L., & Chen, T. F. (2013). Medication information seeking behavior of patients who use multiple medicines: How does it affect adherence? Patient Education and Counseling,92(1), 74–80.
Article
Google Scholar
Cheraghi-Sohi, S., Jeffries, M., Stevenson, F., Ashcroft, D. M., Carr, M., Oliver, K., et al. (2015). The influence of personal communities on the self-management of medication taking: A wider exploration of medicine work. Chronic Illness,11(2), 77–92.
Article
Google Scholar
Conrad, P. (1985). The meaning of medications: Another look at compliance. Social Science and Medicine,20(1), 29–37.
CAS
Article
Google Scholar
Corrigan, P. (2004). How stigma interferes with mental health care. American Psychologist,59(7), 614.
Article
Google Scholar
Corrigan, P. W., Druss, B. G., & Perlick, D. A. (2014). The impact of mental illness stigma on seeking and participating in mental health care. Psychological Science in the Public Interest,15(2), 37–70.
Article
Google Scholar
Deegan, P. E. (2007). The lived experience of using psychiatric medication in the recovery process and a shared decision-making program to support it. Psychiatric Rehabilitation Journal,31(1), 62–69. https://doi.org/10.2975/31.1.2007.62.69.
Article
PubMed
Google Scholar
DiBonaventura, M., Gabriel, S., Dupclay, L., Gupta, S., & Kim, E. (2012). A patient perspective of the impact of medication side effects on adherence: Results of a cross-sectional nationwide survey of patients with schizophrenia. BMC Psychiatry,12(1), 20.
Article
Google Scholar
Hjorth, P., Jørgensen, P., & Sørensen, H. (2013). 980—Psychotropic polypharmacy in patients with severe mental illness. A controlled intervention study aimed to reduce the use of psychotropic medication. European Psychiatry,28, 1.
Article
Google Scholar
Hodgetts, D., Chamberlain, K., Gabe, J., Dew, K., Radley, A., Madden, H.,…,Nikora, L. W. (2011). Emplacement and everyday use of medications in domestic dwellings. Health and Place, 17(1), 353–360.
Article
Google Scholar
Kranke, D. A., Floersch, J., Kranke, B. O., & Munson, M. R. (2011). A qualitative investigation of self-stigma among adolescents taking psychiatric medication. Psychiatric Services,62(8), 893–899.
Article
Google Scholar
Lincoln, A. K., Adams, W., Eyllon, M., Garverich, S., Prener, C. G., Griffith, J.,…,Hopper, K. (2017). The double stigma of limited literacy and mental illness: Examining barriers to recovery and participation among public mental health service users. Society and Mental Health, 7(3), 121–141.
Article
Google Scholar
Link, B. G., & Phelan, J. C. (2006). Stigma and its public health implications. The Lancet,367(9509), 528–529.
Article
Google Scholar
Masnoon, N., Shakib, S., Kalisch-Ellett, L., & Caughey, G. E. (2017). What is polypharmacy? A systematic review of definitions. BMC Geriatrics,17(1), 230.
Article
Google Scholar
Nairn, R. (1999). Does the use of psychiatrists as sources of information improve media depictions of mental illness? A pilot study. Australian and New Zealand Journal of Psychiatry,33(4), 583–589.
CAS
Article
Google Scholar
Olfson, M., Uttaro, T., Carson, W. H., & Tafesse, E. (2005). Male sexual dysfunction and quality of life in schizophrenia. The Journal of Clinical Psychiatry,66, 331–338.
Article
Google Scholar
Pattyn, E., Verhaeghe, M., Sercu, C., & Bracke, P. (2014). Public stigma and self-stigma: Differential association with attitudes toward formal and informal help seeking. Psychiatric Services,65(2), 232–238.
Article
Google Scholar
Pound, P., Britten, N., Morgan, M., Yardley, L., Pope, C., Daker-White, G., et al. (2005). Resisting medicines: A synthesis of qualitative studies of medicine taking. Social Science and Medicine,61(1), 133–155.
Article
Google Scholar
Rambhade, S., Chakarborty, A., Shrivastava, A., Patil, U. K., & Rambhade, A. (2012). A survey on polypharmacy and use of inappropriate medications. Toxicology International,19(1), 68.
Article
Google Scholar
Rüsch, N., Müller, M., Ajdacic-Gross, V., Rodgers, S., Corrigan, P., & Rössler, W. (2014). Shame, perceived knowledge and satisfaction associated with mental health as predictors of attitude patterns towards help-seeking. Epidemiology and Psychiatric Sciences,23(2), 177–187.
Article
Google Scholar
Schwartz, T., Nihalani, N., Jindal, S., Virk, S., & Jones, N. (2004). Psychiatric medication-induced obesity: A review. Obesity Reviews,5(2), 115–121.
CAS
Article
Google Scholar
Shoemaker, S. J., & Ramalho de Oliveira, D. (2008). Understanding the meaning of medications for patients: The medication experience (Author abstract) (Report). Pharmacy World and Science,30(1), 86.
Article
Google Scholar
Sirey, J. A., Bruce, M. L., Alexopoulos, G. S., Perlick, D. A., Friedman, S. J., & Meyers, B. S. (2001). Stigma as a barrier to recovery: Perceived stigma and patient-rated severity of illness as predictors of antidepressant drug adherence. Psychiatric Services,52(12), 1615–1620.
CAS
Article
Google Scholar
Sleath, B., Blalock, S. J., Bender, D., Murray, M., Cerna, A., & Cohen, M. G. (2009). Latinos’ sources of medication and medication information in the United States and their home countries. Patient Education and Counseling,75(2), 279–282.
Article
Google Scholar
Takeuchi, H., Suzuki, T., Remington, G., & Uchida, H. (2015). Antipsychotic polypharmacy and corrected QT interval: A systematic review. The Canadian Journal of Psychiatry,60(5), 215–222.
Article
Google Scholar
Tio, J., LaCaze, A., & Cottrell, W. N. (2007). Ascertaining consumer perspectives of medication information sources using a modified repertory grid technique. Pharmacy World and Science,29(2), 73–80.
Article
Google Scholar
Tran, N., & Castle, D. (2012). Outcomes from a regular medication information programme for consumers with a mental illness. Australasian Psychiatry,20(2), 143–147.
Article
Google Scholar
Turner, J. P., Jamsen, K. M., Shakib, S., Singhal, N., Prowse, R., & Bell, J. S. (2016). Polypharmacy cut-points in older people with cancer: How many medications are too many? Supportive Care in Cancer,24(4), 1831–1840.
Article
Google Scholar
Viswanathan, H., & Lambert, B. L. (2005). An inquiry into medication meanings, illness, medication use, and the transformative potential of chronic illness among African Americans with hypertension. Research in Social and Administrative Pharmacy,1(1), 21–39. https://doi.org/10.1016/j.sapharm.2004.12.007.
Article
PubMed
Google Scholar
Vlasnik, J. J., Aliotta, S. L., & DeLor, B. (2005). Medication adherence: Factors influencing compliance with prescribed medication plans. The Case Manager,16(2), 47–51.
Article
Google Scholar